Description:

Myasthenia Gravis is a neuro-muscular junction dysfunction that often presents to primary care optometry with variable ocular complaints.  This course reviews the ocular and systemic findings in myasthenia gravis and utilizes cases to emphasize how variable and nuanced these cases may present in office.  This course describes how inflammatory triggers including COVID-19 and the vaccine may cause complications and an increased incidence of myasthenia gravis, and the optometrist's role in co-management with neurology.

Course Code:

AOA293-SD

Speaker(s):

Jacqueline Theis, O.D.
dr.jaci.od@gmail.com

Credits:

1

AOA Expiration Date:

2/27/2025

Related News

Doctors of optometry challenge reasoning behind proposed Eyeglass Rule changes at FTC workshop

The recent workshop heard testimony from various stakeholders on the potential impact that proposed changes to the Eyeglass Rule might have on consumer choice and the burden on the practices of doctors of optometry and ophthalmology, which are already understaffed and saddled with other federal regulation. The Federal Trade Commission will use the feedback to determine whether to go forward with its recommendations.

Common coding Qs answered

These are the coding questions your colleagues are asking—and the answers from the AOA’s experts could help you.

The heat is on: Ensure patients’ protective eyewear is, too

Some doctors of optometry may see an increase in patients seeking care during the summer months, whether they’re playing sports or battling dry air conditions. Be prepared to share your expertise.

;